Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens

被引:21
作者
Barnes, Jodie L. [1 ]
Ketheesan, Natkunam [1 ]
机构
[1] James Cook Univ N Queensland, Dept Microbiol & Immunol, Sch Vet & Biomed Sci, Townsville, Qld 4811, Australia
关键词
BALB/c; Burkholderia pseudomallei; C57BL/6; cell-mediated immunity; melioidosis; protective immunity;
D O I
10.1038/sj.icb.7100084
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Melioidosis is a potentially fatal disease caused by the bacterium, Burkholderia pseudomallei. The current study was carried out to determine the mechanisms involved in the development of protective immunity in a murine model of melioidosis. Following intravenous infection with B. pseudomallei, both C57BL/6 and BALB/c mice demonstrated delayed-type hypersensitivity responses and lymphocyte proliferation towards B. pseudomallei antigens, indicating the generation of B. pseudomallei-specific lymphocytes. Adoptive transfer of these lymphocytes to naive C57BL/6 mice was demonstrated by a delayed-type hypersensitivity response. Mice were not protected from a subsequent lethal challenge with a highly virulent strain of B. pseudomallei, suggesting that a single intravenous dose of the bacterium is insufficient to induce a protective adaptive immune response. Attempts to induce resistance in susceptible BALB/c mice used repetitive low-dose exposure to live B. pseudomallei. Immune responses and resistance following subcutaneous immunization with live B. pseudomallei were compared with exposure to heat-killed, culture filtrate and sonicated B. pseudomallei antigens. Compared to heat-killed B. pseudomallei, significant protection was generated in BALB/c mice following immunization with live bacteria. Our studies also demonstrate that the type of immune response generated in vivo is influenced by the antigenic preparation of B. pseudomallei used for immunization.
引用
收藏
页码:551 / 557
页数:7
相关论文
共 34 条
[1]   Adaptive immunity in melioidosis:: a possible role for T cells in determining outcome of infection with Burkholderia pseudomallei [J].
Barnes, JL ;
Warner, J ;
Melrose, W ;
Durrheim, D ;
Speare, R ;
Reeder, JC ;
Ketheesan, N .
CLINICAL IMMUNOLOGY, 2004, 113 (01) :22-28
[2]   Induction of multiple chemokine and colony-stimulating factor genes in experimental Burkholderia pseudomallei infection [J].
Barnes, JL ;
Ulett, GC ;
Ketheesan, N ;
Clair, T ;
Summers, PM ;
Hirst, RG .
IMMUNOLOGY AND CELL BIOLOGY, 2001, 79 (05) :490-501
[3]  
Batoni G, 2000, CLIN EXP IMMUNOL, V119, P270
[4]   Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice [J].
Breitbach, Katrin ;
Klocke, Sonja ;
Tschernig, Thomas ;
van Rooijen, Nico ;
Baumann, Ulrich ;
Steinmetz, Ivo .
INFECTION AND IMMUNITY, 2006, 74 (11) :6300-6309
[5]   ESTABLISHMENT OF STABLE, CELL-MEDIATED-IMMUNITY THAT MAKES SUSCEPTIBLE MICE RESISTANT TO LEISHMANIA-MAJOR [J].
BRETSCHER, PA ;
WEI, GJ ;
MENON, JN ;
BIELEFELDTOHMANN, H .
SCIENCE, 1992, 257 (5069) :539-542
[6]   ISOLATION AND CHARACTERIZATION OF PSEUDOMONAS-PSEUDOMALLEI FLAGELLIN PROTEINS [J].
BRETT, PJ ;
MAH, DCW ;
WOODS, DE .
INFECTION AND IMMUNITY, 1994, 62 (05) :1914-1919
[7]   CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c mice [J].
Chen, YS ;
Hsiao, YS ;
Lin, HH ;
Liu, Y ;
Chen, YL .
INFECTION AND IMMUNITY, 2006, 74 (03) :1699-1705
[8]   Exposure to Burkholderia pseudomallei induces cell-mediated immunity in healthy individuals [J].
Govan, B ;
Ketheesan, N .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (06) :585-587
[9]   Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection [J].
Haque, A ;
Easton, A ;
Smith, D ;
O'Garra, A ;
Van Rooijen, N ;
Lertmemongkolchai, G ;
Titball, RW ;
Bancroft, GJ .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (03) :370-379
[10]   A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins [J].
Haque, Ashraful ;
Chu, Karen ;
Easton, Anna ;
Stevens, Mark P. ;
Galyov, Edouard E. ;
Atkins, Tim ;
Titball, Rick ;
Bancroft, Gregory J. .
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (09) :1241-1248